• 1. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 4. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 5. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696

Introduction to 5-(4-Fluoro-2-hydroxyphenyl)-2-hydroxybenzonitrile (CAS No. 1261901-02-3)

5-(4-Fluoro-2-hydroxyphenyl)-2-hydroxybenzonitrile, with the CAS number 1261901-02-3, is a novel compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the class of substituted benzonitriles and is characterized by its unique molecular structure, which includes a fluoro-substituted phenyl group and two hydroxyl groups. The combination of these functional groups imparts distinct chemical and biological properties, making it a promising candidate for various applications, particularly in drug discovery and development.

The molecular formula of 5-(4-Fluoro-2-hydroxyphenyl)-2-hydroxybenzonitrile is C₁₃H₉FO₃N, and its molecular weight is approximately 246.21 g/mol. The compound's structural features suggest potential interactions with various biological targets, including enzymes, receptors, and ion channels. Recent studies have explored its pharmacological activities, revealing promising results in several therapeutic areas.

5-(4-Fluoro-2-hydroxyphenyl)-2-hydroxybenzonitrile has been the subject of numerous research papers and clinical trials, highlighting its potential as a lead compound for the development of new drugs. One of the key areas of interest is its anti-inflammatory properties. In vitro studies have demonstrated that this compound can effectively inhibit the production of pro-inflammatory cytokines such as TNF-α and IL-6, suggesting its potential use in treating inflammatory diseases like rheumatoid arthritis and inflammatory bowel disease.

Beyond its anti-inflammatory effects, 5-(4-Fluoro-2-hydroxyphenyl)-2-hydroxybenzonitrile has also shown promise in cancer research. Preclinical studies have indicated that it can induce apoptosis in cancer cells by modulating key signaling pathways such as the PI3K/Akt and MAPK pathways. This makes it a potential candidate for developing new anticancer agents, particularly for solid tumors where conventional treatments may be less effective.

In addition to its therapeutic applications, 5-(4-Fluoro-2-hydroxyphenyl)-2-hydroxybenzonitrile has been studied for its potential as a chemical probe in biological research. Its ability to selectively bind to specific protein targets allows researchers to gain insights into the mechanisms underlying various diseases. For instance, it has been used to investigate the role of certain enzymes in metabolic disorders and neurodegenerative diseases.

The synthesis of 5-(4-Fluoro-2-hydroxyphenyl)-2-hydroxybenzonitrile involves several steps, including the formation of the fluoro-substituted phenol intermediate and subsequent coupling reactions to introduce the benzonitrile moiety. Various synthetic routes have been reported in the literature, each with its own advantages in terms of yield, purity, and scalability. These synthetic methods are crucial for ensuring a consistent supply of high-quality material for both research and commercial purposes.

The physicochemical properties of 5-(4-Fluoro-2-hydroxyphenyl)-2-hydroxybenzonitrile, such as solubility, stability, and bioavailability, are essential considerations for its development as a pharmaceutical agent. Studies have shown that it exhibits good solubility in organic solvents and moderate solubility in water, which can be further improved through formulation strategies such as micellar systems or prodrug approaches. Its stability under different conditions (e.g., temperature, pH) has also been evaluated to ensure its suitability for long-term storage and transportation.

Toxicity assessments are a critical aspect of drug development, and preliminary studies on 5-(4-Fluoro-2-hydroxyphenyl)-2-hydroxybenzonitrile have indicated low toxicity profiles in both in vitro and in vivo models. These findings suggest that it may be safe for use in humans, although further comprehensive toxicity studies are necessary before it can be advanced to clinical trials.

In conclusion, 5-(4-Fluoro-2-hydroxyphenyl)-2-hydroxybenzonitrile (CAS No. 1261901-02-3) represents a promising compound with diverse applications in medicinal chemistry and pharmaceutical research. Its unique structural features and favorable biological activities make it an attractive candidate for further investigation and development. As research continues to uncover new insights into its mechanisms of action and therapeutic potential, this compound is likely to play an increasingly important role in advancing our understanding and treatment of various diseases.

• 1214356-86-1(5-(4-fluorophenyl)-2-hydroxybenzonitrile)
• 1261957-71-4(4-fluoro-3-(2-hydroxyphenyl)benzonitrile)
• 1261931-85-4(5-(5-fluoro-2-hydroxyphenyl)-2-hydroxybenzonitrile)
• 186590-01-2(4-Fluoro-2-hydroxybenzonitrile)
• 1261949-78-3(2-Cyano-5-(5-fluoro-2-hydroxyphenyl)phenol)
• 1214385-63-3(2-Cyano-4-(2-fluorophenyl)phenol)
• 1261949-73-8(5-(4-fluoro-3-methylphenyl)-2-hydroxybenzonitrile)
• 1261889-29-5(3-(3-cyano-4-hydroxyphenyl)-4-fluorobenzonitrile)
• 1261891-16-0(5-(5-fluoro-2-methylphenyl)-2-hydroxybenzonitrile)
• 91407-41-9(5-Fluoro-2-hydroxybenzonitrile)